Home / Knowledge Centre /
Case study

Seamless adoption of mid-study protocol change

Protocol changes—even those made because a drug is performing better than expected—can wreak havoc with study timelines and budgets. When one emerging biotech faced a protocol change that would render the Interactive Response Technology (IRT) system for Part II of the study unusable, Almac staff snapped into action with a creative, schedule-saving solution.

View Resource
Almac Logo

Almac Clinical Technologies

Almac Clinical Technologies is here to help the biopharmaceutical industry bring new therapies to those in need by empowering clinical trial sponsors to proactively manage sites, patients, and clinical trial supplies through our industry-leading Interactive Response Technology (IRT) and expert consultancy.

Almac Clinical Technologies is uniquely positioned to unlock new efficiencies in the clinical supply chain and to help achieve greater predictability in your projects and programs.

Our professionals are dedicated to delivering high-quality Interactive Response Technology (IRT) solutions, dependable professional services, and reliable customer service. Our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies